Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells-Reference-Cited by-同舟云学术

Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells

Published:2005-08-28 Issue:9 Volume:11 Page:992-997
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Mizukami Yusuke,Jo Won-Seok,Duerr Eva-Maria,Gala Manish,Li Jingnan,Zhang Xiaobo,Zimmer Michael A,Iliopoulos Othon,Zukerberg Lawrence R,Kohgo Yutaka,Lynch Maureen P,Rueda Bo R,Chung Daniel C

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1294.pdf

Reference30 articles.

1. Denko, N.C. et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22, 5907–5914 (2003).

2. Carmeliet, P. et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485–490 (1998).

3. Pugh, C.W. & Ratcliffe, P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677–684 (2003).

4. Tang, N. et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6, 485–495 (2004).

5. Kung, A.L., Wang, S., Klco, J.M., Kaelin, W.G. & Livingston, D.M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6, 1335–1340 (2000).

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of preoperative peripheral blood inflammatory biomarkers in extrahepatic cholangiocarcinoma: a systematic review and meta-analysis;Frontiers in Oncology;2024-08-29

2. Predictive significance of inflammatory markers in the survival of older Indian patients with cancer: a single-center prospective analysis;ecancermedicalscience;2024-08-22

3. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

4. Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors;International Review of Cell and Molecular Biology;2024

5. Alleviating hypoxia to improve cancer immunotherapy;Oncogene;2023-10-26